Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU

ABSTRACT: In phenylketonuria, casein glycomacropeptide (CGMP) requires modification with the addition of some essential and semi essential amino acids to ensure suitability as a protein substitute. The optimal amount and ratio of additional amino acids is undefined. AIM: A longitudinal, parallel, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Daly, A., Evans, S., Chahal, S., Santra, S., Pinto, A., Jackson, R., Gingell, C., Rocha, J., Van Spronsen, F. J., MacDonald, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377744/
https://www.ncbi.nlm.nih.gov/pubmed/30770754
http://dx.doi.org/10.1186/s13023-019-1011-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377744/
https://www.ncbi.nlm.nih.gov/pubmed/30770754
http://dx.doi.org/10.1186/s13023-019-1011-y

Ejemplares similares